Dimitrios Paraskevis
- Virology top 0.5%
- HIV Research and Treatment 76
- Infectious Diseases top 0.2%
- HIV/AIDS Research and Interventions 72
- HIV/AIDS drug development and treatment 38
- SARS-CoV-2 and COVID-19 Research 32
- COVID-19 Clinical Research Studies 18
- Hepatology top 0.5%
- Hepatitis C virus research 37
- Epidemiology top 1%
- HIV, Drug Use, Sexual Risk 54
- Hepatitis B Virus Studies 34
- Modeling and Simulation top 1%
- Co-authors
- Angelos HatzakisGkikas MagiorkinisEvangelia Georgia KostakiVana SypsaSotirios TsiodrasGeorgios K. NikolopoulosEmmanouil MagiorkinisGeorge Sourvinos
- Journals
- Nature (1 paper)Proceedings of the National Academy of Sciences (2 papers)The Lancet (1 paper)
- Partner nations
- GreeceUnited StatesUnited Kingdom
In The Last Decade
Dimitrios Paraskevis
203 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Virology 1.5k
- Infectious Diseases 3.2k
- Hepatology 1.0k
- Epidemiology 2.3k
- Modeling and Simulation 289
Countries citing papers authored by Dimitrios Paraskevis
This map shows the geographic impact of Dimitrios Paraskevis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitrios Paraskevis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitrios Paraskevis more than expected).
Fields of papers citing papers by Dimitrios Paraskevis
This network shows the impact of papers produced by Dimitrios Paraskevis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitrios Paraskevis. The network helps show where Dimitrios Paraskevis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dimitrios Paraskevis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 10 | |
| 4 | 2023 | 19 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 4 | |
| 8 | 2022 | 11 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 13 | |
| 11 | 2021 | 7 | |
| 12 | 2021 | 25 | |
| 13 | 2021 | 28 | |
| 14 | 2021 | 3 | |
| 15 | 2020 | 40 | |
| 16 | 2018 | 21 | |
| 17 | 2014 | 16 | |
| 18 | 2014 | 36 | |
| 19 | European recommendations for the clinical use of HIV drug resistance testing: 2011 update. | 2011 | 104 |
| 20 | 2000 | 17 |
About Dimitrios Paraskevis
Dimitrios Paraskevis is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 212 papers that have together received 5.4k indexed citations. Recurring topics across this work include HIV Research and Treatment (76 papers), HIV/AIDS Research and Interventions (72 papers), HIV, Drug Use, Sexual Risk (54 papers), HIV/AIDS drug development and treatment (38 papers), Hepatitis C virus research (37 papers), Hepatitis B Virus Studies (34 papers), SARS-CoV-2 and COVID-19 Research (32 papers) and COVID-19 Clinical Research Studies (18 papers). The work is most often cited by research in Virology (1.5k citations), Infectious Diseases (3.2k citations) and Hepatology (1.0k citations). Dimitrios Paraskevis has collaborated with scholars based in Greece, United States and United Kingdom. Frequent co-authors include Angelos Hatzakis, Gkikas Magiorkinis, Evangelia Georgia Kostaki, Vana Sypsa, Sotirios Tsiodras, Georgios K. Nikolopoulos, Emmanouil Magiorkinis, George Sourvinos, Anne–Mieke Vandamme and Samuel R. Friedman. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.